Vectormune FP ILT
البلد: الاتحاد الأوروبي
اللغة: الأيسلاندية
المصدر: EMA (European Medicines Agency)
نشرة المعلومات
(PIL)
27-05-2024
خصائص المنتج
(SPC)
27-05-2024
العنصر النشط:
recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live
متاح من:
CEVA-Phylaxia Co. Ltd.
INN (الاسم الدولي):
Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)
المجموعة العلاجية:
Kjúklingur
الخصائص العلاجية:
For active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
الوضع إذن:
Leyfilegt
تاريخ الترخيص:
2020-12-09
نشرة المعلومات
OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Nýjustu upplýsingar um þetta dýralyf er að finna á
upplýsingasíðu dýralyfja.
اقرأ الوثيقة كاملة
خصائص المنتج
OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Nýjustu upplýsingar um þetta dýralyf er að finna á
upplýsingasíðu dýralyfja.
اقرأ الوثيقة كاملة
